All Stories

  1. Optical coherence tomography angiography detects retinal vascular alterations in different phases of multiple sclerosis

    Article • Multiple Sclerosis Journal, March 2018, SAGE Publications

    Dr Roberta Lanzillo

  2. No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1b therapy in relapsing–remitting multiple sclerosis (the ARIANNA study)

    Article • Multiple Sclerosis Journal, July 2016, SAGE Publications

    Dr Roberta Lanzillo

  3. The Dress: Transforming a web viral event into a scientific survey

    Article • Multiple Sclerosis and Related Disorders, May 2016, Elsevier

    Dr Roberta Lanzillo

  4. Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study

    Article • Expert Opinion on Drug Delivery, March 2016, Informa Healthcare

    Dr Roberta Lanzillo, Valentina Panetta

  5. Can people with multiple sclerosis actually understand what they read in the Internet age?

    Article • Journal of Clinical Neuroscience, March 2016, Elsevier

    Dr Roberta Lanzillo

  6. In vivo dentate nucleus MRI relaxometry correlates with previous administration of Gadolinium-based contrast agents

    Article • European Radiology, February 2016, Springer Science + Business Media

    Dr Roberta Lanzillo

  7. The management of multiple sclerosis by reference centers in south of Italy: a 2011 survey on health demands and needs in Campania region

    Article • Neurological Sciences, October 2015, Springer Science + Business Media

    Dr Roberta Lanzillo

  8. Lesion Load May Predict Long-Term Cognitive Dysfunction in Multiple Sclerosis Patients

    Article • PLoS ONE, March 2015, PLOS

    Dr Roberta Lanzillo

  9. Uric acid in relapsing–remitting multiple sclerosis: a 2-year longitudinal study

    Article • Deutsche Zeitschrift für Nervenheilkunde, February 2015, Springer Science + Business Media

    Dr Roberta Lanzillo

  10. Vitamin K cream reduces reactions at the injection site in patients with relapsing–remitting multiple sclerosis treated with subcutaneous interferon beta – VIKING study

    Article • Multiple Sclerosis Journal, February 2015, SAGE Publications

    Dr Roberta Lanzillo

  11. Uric acid: a potential biomarker of multiple sclerosis and of its disability

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2015, De Gruyter

    Dr Roberta Lanzillo

  12. JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level

    Article • Therapeutics and Clinical Risk Management, October 2014, Taylor & Francis

    Master raffaele iuzzi, Marcello Moccia, Dr Roberta Lanzillo

  13. Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab

    Article • JAMA Neurology, August 2014, American Medical Association (AMA)

    Dr Roberta Lanzillo

  14. Internal Jugular Vein Blood Flow in Multiple Sclerosis Patients and Matched Controls

    Article • PLoS ONE, March 2014, PLOS

    Dr Roberta Lanzillo

  15. Chronic cerebrospinal venous insufficiency in multiple sclerosis: a highly prevalent age-dependent phenomenon

    Article • BMC Neurology, January 2013, Springer Science + Business Media

    Dr Roberta Lanzillo

  16. Multiple Sclerosis: Cerebral Circulation Time

    Article • Radiology, March 2012, Radiological Society of North America (RSNA)

    Dr Roberta Lanzillo

  17. Biochemical Parameters Alterations in Multiple Sclerosis: A Longitudinal Study and Review of the Literature

    Article • Pharmacology &amp Pharmacy, January 2012, Scientific Research Publishing, Inc,

    Dr Roberta Lanzillo

  18. Early detection of biventricular involvement in myotonic dystrophy by tissue Doppler

    Article • International Journal of Cardiology, May 2007, Elsevier

    Dr Roberta Lanzillo

  19. Modifications of brain tissue volumes in facioscapulohumeral dystrophy

    Article • NeuroImage, September 2006, Elsevier

    Dr Roberta Lanzillo

  20. Neuropsychological assessment, quantitative MRI and ApoE gene polymorphisms in a series of MS patients treated with IFN beta-1b

    Article • Journal of the Neurological Sciences, June 2006, Elsevier

    Dr Roberta Lanzillo

  21. The glycopeptide CSF114(Glc) detects serum antibodies in multiple sclerosis

    Article • Journal of Neuroimmunology, October 2005, Elsevier

    Dr Roberta Lanzillo

  22. Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load

    Article • NeuroImage, February 2003, Elsevier

    Dr Roberta Lanzillo

  23. Two new mutations in the myophosphorylase gene in Italian patients with McArdle's disease

    Article • Neuromuscular Disorders, June 2002, Elsevier

    Dr Roberta Lanzillo

  24. Transient Muteness Followed by Dysarthria in Patients with Pontomesencephalic Stroke

    Article • Cerebrovascular Diseases, January 1999, Karger Publishers

    Dr Roberta Lanzillo